Primrose Therapeutics

Primrose Therapeutics is engaged in the development of treatments for polycystic kidney disease. Founded by Eric Rowinsky in 2010, Primrose Therapeutics is headquartered in New York.
The Pulse of New York Tech
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.